Topical calcipotriol before ablative fractional laser-assisted photodynamic therapy enhances treatment outcomes for actinic keratosis in Fitzpatrick grades.

Slides:

Advertisements

Similar presentations

Secukinumab sustains early patient-reported outcome benefits through 1 year: Results from 2 phase III randomized placebo-controlled clinical trials comparing.

Advertisements

Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ on the trunk and extremities with ablative fractional laser-assisted.

Clavi syphilitici–an unusual presentation of syphilis

Optimal time to provide skin cancer and photoprotection education to pediatric solid organ transplant recipients Lily Chen, BA, Feng Gao, MD, PhD, MPH,

Lauren Kwa, BA, Jonathan I. Silverberg, MD, PhD, MPH

Kavitha K. Reddy, MD, Jeremy A. Brauer, MD, Roy G. Geronemus, MD

Superior efficacy of oral fluconazole 400 mg daily versus oral fluconazole 200 mg daily in the treatment of cutaneous leishmania major infection: A randomized.

A girl with a solitary red bulla

Treatment of folliculitis decalvans with photodynamic therapy: Results in 10 patients Laura Miguel-Gomez, MD, Sergio Vano-Galvan, MD, PhD, Bibiana Perez-Garcia,

Efficacy of the long-pulsed 1064-nm neodymium:yttrium-aluminum-garnet laser (LPND) (rejuvenation mode) in the treatment of papulopustular rosacea (PPR):

Yul W. Yang, MD, PhD, David J. DiCaudo, MD

Image registration of sequential transparent photographs to localize and detect new versus recurrent tumors in dermatologic and Mohs micrographic surgery

Baldness reversed by chemotherapy

Thrombosis-induced ulcerations of the lower legs with coexistent anetoderma due to anti-thrombin III deficiency Emily R. Clark, PA-C, Joseph C. English

Array of cutaneous adverse effects associated with sorafenib

Elana Putterman, BS, Leslie Castelo-Soccio, MD, PhD

María Jesús Suárez Valladares, MD, Manuel Ángel Rodríguez Prieto, MD

Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to.

Imiquimod 5% cream for treatment of HIV-negative Kaposi's sarcoma skin lesions: A phase I to II, open-label trial in 17 patients Noël Emile Célestin.

Two randomized, double-blind, placebo-controlled studies of fluticasone propionate lotion 0.05% for the treatment of atopic dermatitis in subjects from.

The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study Hsien-Yi Chiu, MD, Tsen-Fang.

Treatment of notalgia paresthetica with botulinum toxin A: A double-blind randomized controlled trial Catherine Maari, MD, FRCPC, Philippe Marchessault,

JAK inhibitors in dermatology: The promise of a new drug class

Laser-assisted drug delivery: Enhanced response to ingenol mebutate after ablative fractional laser treatment Stephan Alexander Braun, MD, Peter Hevezi,

Sara A. Farber, BA, Sara Samimi, MD, Misha Rosenbach, MD

Effect of appearance-based education compared with health-based education on sunscreen use and knowledge: A randomized controlled trial William Tuong,

Pharmacy costs of specialty medications for plaque psoriasis in the United States Eric J. Yang, BS, Kristen M. Beck, MD, Sahil Sekhon, MD, Tina Bhutani,

A pilot trial of treprostinil for the treatment and prevention of digital ulcers in patients with systemic sclerosis Lorinda Chung, MD, David Fiorentino,

Applying for dermatology residency is difficult and expensive

Efficacy of intralesional photodynamic therapy for the treatment of hidradenitis suppurativa Manuel Ángel Rodríguez-Prieto, MD, Luis Miguel Valladares-Narganes,

Immersion foot associated with the overuse of ice, cold water, and fans: A distinctive clinical presentation complicating the syndrome of erythromelalgia

308-nm excimer laser therapy in alopecia areata

Sally Helen Ibbotson, MD

Reply to: “Comment on ‘Activation of melanocytes in idiopathic guttate hypomelanosis after 5-fluorouracil infusion using a tattoo machine: Preliminary.

Clinical and photographic assessment of lichen planopilaris treatment efficacy Aline Donati, MD, Philipe Assouly, MD, Bruno Matard, MD, Corinne Jouanique,

Google search trends for tanning salons: Temporal patterns indicate peak interest in mid spring Derek D. Reed, PhD, BCBA-D Journal of the American Academy.

Successful use of a modified Goeckerman regimen in the treatment of generalized prurigo nodularis Eric Sorenson, AB, Ethan Levin, MD, John Koo, MD, Timothy.

A survey-based study on nail examinations at an American Academy of Dermatology free skin cancer screening Dayoung Ko, BS, Shari R. Lipner, MD, PhD

Loss of efficacy of secukinumab for psoriasis at 24 to 32 weeks

Infectious rash after riding elephants

Lenalidomide in treatment-refractory cutaneous lupus erythematosus: Efficacy and safety in a 52-week trial Lauren Okon, MD, Misha Rosenbach, MD, Michael.

Photorejuvenation induced by 5-aminolevulinic acid photodynamic therapy in patients with actinic keratosis: A histologic analysis Min Young Park, MD,

Lip edema Journal of the American Academy of Dermatology

Topical tacrolimus for chronic actinic dermatitis

Stephanie D. Gan, MD, Sarah H

Successful treatment of actinic keratoses using nonthermal atmospheric pressure plasma: A case series Peter C. Friedman, MD, PhD, Vandana Miller, MD,

Expression of interleukin-1 alpha in amicrobial pustulosis of the skin folds with complete response to anakinra Emmanuelle Amazan, MD, Khaled Ezzedine,

Isotretinoin for high-grade or refractory epidermal growth factor receptor inhibitor-related acneiform papulopustular eruptions Herbert C. Chiang, MD,

Verrucous epidermal nevus (VEN) successfully treated with indocyanine green (ICG) photodynamic therapy (PDT) Tae In Kim, MD, Ki Heon Jeong, MD, Min Kyung.

Olga Vornicova, MD, Gil Bar-Sela, MD JAAD Case Reports

Pooja H. Rambhia, BA, Ivan J. Stojanov, DMD, Joshua Arbesman, MD

Medicaid acceptance among pediatric dermatologists

Christopher T. Cassetty, MD, Andrew F. Alexis, MD, MPH, Jerome L

Modification of the nail psoriasis severity index

Tofacitinib therapy for children with severe alopecia areata

Jose Fernández-Vozmediano, PhD, Jose Armario-Hita, MD

Michelle A. Pipitone, MD, Brian Adams, MD, MPH, Anita Sheth, MD, T

Eyebrow transplantation: Alternative body sites as a donor source

Recurrence of nevus depigmentosus after an autologous epidermal graft

Gaps in pain management in dermatology: A needs assessment from Canada

Brittany G. Craiglow, MD, Brett A. King, MD, PhD

Deede Y. Liu, MD, Muhammad I. Gul, BS, Jo Wick, PhD, Anand N

Anti-aging effects of ingenol mebutate for patients with actinic keratosis Miri Kim, MD, PhD, Yujin Jung, MD, Jongsic Kim, MD, Seo-won Jeong, BS, Yu Ri.

Randomized study of topical tacrolimus ointment as possible treatment for resistant idiopathic pruritus ani Erwin Suys, MD Journal of the American Academy.

“Boot foot” with pseudomonas colonization

A randomized, controlled, prospective clinical study comparing a novel skin closure device to conventional suturing Hadeel Mitwalli, MD, Christopher.

Orit Kaidar-Person, MD, Ayelet Eran, MD, Gil Bar-Sela, MD

The JAAD adopts the CONSORT statement

Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults Eric L. Simpson, MD, MCR,

Stuart M. Goldsmith, MD, Armand B. Cognetta, MD

Presentation transcript:

Topical calcipotriol before ablative fractional laser-assisted photodynamic therapy enhances treatment outcomes for actinic keratosis in Fitzpatrick grades III-V skin: A prospective randomized clinical trial Jeong-Wan Seo, MD, Ki-Hoon Song, MD, PhD Journal of the American Academy of Dermatology Volume 78, Issue 4, Pages 795-797 (April 2018) DOI: 10.1016/j.jaad.2017.11.027 Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

Fig 1 Representative clinical images of actinic keratosis lesions from patients before and after treatment with AFL-PDT with and without calcipotriol pretreatment. Patients underwent 2-week pretreatment with topical calcipotriol (CAL-AFL-PDT, Olsen grade III, upper row) or placebo (AFL-PDT, Olsen grade III, lower row). AFL-PDT, Ablative fractional laser-assisted photodynamic therapy; CAL-AFL-PDT, AFL-PDT with calcipotriol pretreatment. Journal of the American Academy of Dermatology 2018 78, 795-797DOI: (10.1016/j.jaad.2017.11.027) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions